Hearing loss injection study pulled before it began
NCT ID NCT06437054
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study aimed to test whether a mixture of dexamethasone, hyaluronic acid, and a green dye could be safely injected into the ear to treat certain types of hearing loss that don't improve with standard treatments. The plan was to enroll 26 adults with sudden hearing loss, Meniere's disease, or other inner-ear conditions. However, the study was withdrawn before any participants were enrolled, so no data were collected.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Dexamethasone, hyaluronic acid, and indocyanine green
- What this could lead to
- If it had worked, this could point toward a new way to deliver drugs into the ear for stubborn hearing loss.
- What could go wrong
- The study was withdrawn before it started, so no results exist. Even if it had run, it was a very small pilot—too early to know if the approach would be safe or effective.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEARING LOSS, SENSORINEURAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can eye movements reveal the hidden toll of hearing loss?
- Smart sensors could predict falls in older adults with dizziness
- Can a 3-Minute video beat a pamphlet at saving hearing?
- Chilling the inner ear: a cool new way to shield hearing?
- Could a blood concentrate make cochlear implants work better?
- One-Time injection aims to restore hearing in children born deaf